{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:11:07Z","timestamp":1793383867033,"version":"4.5.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2002,9]]},"DOI":"10.1378\/chest.122.3.1093","type":"journal-article","created":{"date-parts":[[2003,6,14]],"date-time":"2003-06-14T00:09:19Z","timestamp":1055549359000},"page":"1093-1096","source":"Crossref","is-referenced-by-count":102,"title":["Clinical Response of Rheumatoid Arthritis-Associated Pulmonary Fibrosis to Tumor Necrosis Factor-\u03b1 Inhibition"],"prefix":"10.1016","volume":"122","author":[{"given":"Robert","family":"Vassallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Matteson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Charles F.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.122.3.1093_bib1","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1164\/ajrccm.161.2.ats3-00","article-title":"Idiopathic pulmonary fibrosis: diagnosis and treatment. International Consensus Statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS)","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.122.3.1093_bib2","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/0049-0172(87)90020-5","article-title":"Pulmonary fibrosis in rheumatoid arthritis: a review of clinical features and therapy","volume":"16","author":"Roschmann","year":"1987","journal-title":"Semin Arthritis Rheum"},{"key":"10.1378\/chest.122.3.1093_bib3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/ajrccm.158.1.9709089","article-title":"Colchicine vs prednisone in the treatment of idiopathic pulmonary fibrosis: a randomized prospective study","volume":"158","author":"Douglas","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.122.3.1093_bib4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/344245a0","article-title":"Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosis","volume":"344","author":"Piguet","year":"1990","journal-title":"Nature"},{"key":"10.1378\/chest.122.3.1093_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1172\/JCI118029","article-title":"Expression of a tumor necrosis factor-\u03b1 transgene in murine lung causes lymphocytic and fibrosing alveolitis: a mouse model of progressive pulmonary fibrosis","volume":"96","author":"Miyazaki","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1378\/chest.122.3.1093_bib6","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/S0140-6736(99)05246-0","article-title":"Infliximab (chimeric anti-tumour necrosis factor \u03b1 monoclonal antibody) vs placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial; ATTRACT Study Group","volume":"354","author":"Maini","year":"1999","journal-title":"Lancet"},{"key":"10.1378\/chest.122.3.1093_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1183\/09031936.94.07030515","article-title":"Treatment by human recombinant soluble TNF receptor of pulmonary fibrosis induced by bleomycin or silica in mice","volume":"7","author":"Piguet","year":"1994","journal-title":"Eur Respir J"},{"key":"10.1378\/chest.122.3.1093_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/rr162","article-title":"Growth factors in idiopathic pulmonary fibrosis: relative roles","volume":"3","author":"Allen","year":"2002","journal-title":"Respir Res"},{"key":"10.1378\/chest.122.3.1093_bib9","doi-asserted-by":"crossref","first-page":"954","DOI":"10.4049\/jimmunol.158.2.954","article-title":"TNF-\u03b1\u2013mediated lung cytokine networking and eosinophil recruitment in pulmonary fibrosis","volume":"158","author":"Zhang","year":"1997","journal-title":"J Immunol"},{"key":"10.1378\/chest.122.3.1093_bib10","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis; Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.122.3.1093_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00000478-200001000-00003","article-title":"Idiopathic nonspecific interstitial pneumonia: prognostic significance of cellular and fibrosing patterns; survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia","volume":"24","author":"Travis","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1378\/chest.122.3.1093_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00000441-200101000-00012","article-title":"Potential pathogenesis and clinical aspects of pulmonary fibrosis associated with rheumatoid arthritis","volume":"321","author":"Gochuico","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1378\/chest.122.3.1093_bib13","first-page":"A25","article-title":"An open label pilot study to determine the potential efficacy of TNFR.FC (Enbrel\u00ae, Etanercept) in the treatment of usual interstitial pneumonitis (UIP) [abstract]","author":"Niden","year":"2001","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216472168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216472168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T12:00:43Z","timestamp":1682510443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216472168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["S0012369216472168"],"URL":"https:\/\/doi.org\/10.1378\/chest.122.3.1093","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}